Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; (CSE: $BE.C), (TSXV: $RLV.V), (NASDAQ: $MBII), (TSXV: $OGI.V),
(CSE: $EHC.C)
Pt. Roberts, WA; Delta, BC –June 4, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to
watch plus insight from thought leaders and experts.
Listen to the podcast: http://www.investorideas.com/Audio/Podcasts/2018/060418-CannabisNews.mp3
Read this in full at http://www.investorideas.com/news/2018/cannabis/06041Potcast-CSEBEEHCTSXVRLVOGINASDAWMBII.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast –
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts. Today we are looking at announcements from Beleave Inc. (CSE : BE ,OTCQX :s BLEVF), Relevium Technologies Inc. (TSX-V:
RLV , OTCQB: RLLVF), Marrone Bio Innovations, Inc. (NASDAQ
: MBII),
Organigram Holdings Inc. (TSX
V: OGI , OTCQB:OGRMF
) and Eviana Health Corporation (CSE:
EHC , OTC: EVNNF).
First
looking at Beleave Inc., a diversified biotech company with a purpose-built
ACMPR licensed cannabis facility near Hamilton, Ontario and patient services
clinics operating across Ontario under the Medi-Green brand, announced that the
Company has been selected to operate one of Saskatchewan's upcoming cannabis
retail stores.
Cannabis
retail stores in the province must be standalone operations, selling only
cannabis, cannabis accessories and ancillary items as defined by Saskatchewan
Liquor and Gaming Authority ("SLGA"). Beleave has 45 days to begin
the permitting process. As a condition of the permit, the Company must be
operating within 12 months of legalization. The permit will not take effect
until legalization occurs, expected later this year.
"This
announcement confirms our commitment to expand the reach of Beleave's product
and service offerings throughout our Canadian network, whether it be through
retail stores or online sales and shipping," said Beleave CEO Andrew Wnek.
"We're excited about being a part of the Saskatchewan community, and we
thank the SLGA for including us in the province's upcoming cannabis retail
system."
Relevium
Technologies Inc. announced that, through its wholly-owned subsidiary
Biocannabix (“BCX”), it has selected a 93,000 square foot facility in Montreal,
Quebec with the objective of cultivating premium organic cannabis.
With the
assistance of PipeDreemz Inc., Relevium has conducted initial assessment on the
facility, a 93,000 Sq. Ft industrial building located adjacent to the
TransCanada Highway, Trudeau International Airport and about 20 minutes from
downtown Montreal. The building has been selected as a desirable location with
a low risk profile for the application submission to Health Canada for an ACMPR
cultivation license. Biocannabix will be leveraging the vast experience of lead
consultant George Routhier and his company PipeDreemz Inc., a company with a
remarkable 100% rate of success with ACMPR licensing from Health Canada.
Aurelio
Useche, CEO of Relevium stated: “The strategy of Biocannabix will not be
catered around being the lowest cost producer, but rather on being a premium
and custom producer focused on consumer packaged goods to be sold through
Relevium’s current and new brands.” Mr. Useche stated further: “The value in
the supply chain will be in developing trusted, unique, ultra-premium product
for luxurious brands.”
Marrone Bio
Innovations, Inc., a leading provider of bio-based pest management and plant
health products for the agriculture, turf and ornamental and water treatment
markets, announced the launch of REGALIA CG, GRANDEVO CG and VENERATE CG, a
portfolio of products designed to control highly destructive pests and
diseases, including powdery mildew, mites, thrips and aphids, during Cannabis
production and home gardening.
REGALIA CG,
GRANDEVO CG and VENERATE CG are multi-state-approved and extremely effective
biological crop protection solutions for clean green cultivation, with the
ability to generate increased yield and improved quality by reducing stresses
from plant disease and insect and mite pests to the plant. When incorporated
into an Integrated Pest Management (IPM) program, these products can serve as
the fundamental difference for successful growers.
Organigram
Holdings Inc. and Eviana Health Corporation jointly announced that the
Companies have entered into a non-binding term sheet whereby Organigram will
make a significant equity investment into Eviana. Additionally, the Term
Sheet contemplates Organigram entering into an offtake agreement with Eviana
for up to 50% of the cannabidiol (“CBD”) production of Eviana for a period of
five years, subject to adjustment based on Organigram’s equity interest in
Eviana.
“This
agreement is a key facet of our ongoing international expansion efforts,”
explains Greg Engel, CEO, Organigram. “Our investment and concurrent offtake
agreement with Eviana will provide Organigram with a source of low-cost,
high-quality CBD for the burgeoning medical market within Europe. The proven
cultivation and processing costing model that Eviana has developed will allow
us to bring a range of innovative products to the global CBD marketplace.”
This
potential investment supports Organigram’s aggressive growth strategy and helps
ensure that Organigram is well prepared to meet the international demand for
CBD oil.
Investor ideas reminds all listeners to read
our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
